LACEY PULLEY: Open Payments
NPI 1780126920 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 19 payments from 12 companies in 2025. Trend: 2023 $138 · 2024 $450 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Verona Pharma, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| HARMONY BIOSCIENCES LLC | 1 | $24 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Electromed, Inc. | 2 | $19 |
| Amgen Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: DUPIXENT, GLASSIA, Ohtuvayre, WAKIX, LUMRYZ, SMARTVEST, TEZSPIRE, Sunosi.
Industry payments across IN — which companies pay providers there.
